BRA
AMGN icon

Biechele Royce Advisors’s Amgen AMGN Stock Holding History

Biechele Royce Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$20.9M Sell
64,848
-2,224
-3% -$727K 6.89% 4
2024
Q2 		$21M Sell
67,072
-3
-0% -$881 7.08% 3
2024
Q1 		$19.1M Buy
67,075
+950
+1% +$278K 6.32% 3
2023
Q4 		$19M Buy
66,125
+123
+0.2% +$33.5K 6.24% 3
2023
Q3 		$17.7M Sell
66,002
-12
-0% -$3K 6.54% 3
2023
Q2 		$14.7M Buy
66,014
+3,293
+5% +$764K 5.11% 4
2023
Q1 		$15.2M Buy
62,721
+2,788
+5% +$684K 5.64% 4
2022
Q4 		$15.7M Buy
59,933
+1,153
+2% +$309K 6.42% 1
2022
Q3 		$13.2M Buy
58,780
+877
+2% +$213K 6.23% 3
2022
Q2 		$14.1M Buy
57,903
+2,064
+4% +$506K 6.26% 2
2022
Q1 		$13.5M Buy
55,839
+1,685
+3% +$387K 5.38% 4
2021
Q4 		$12.2M Buy
54,154
+4,736
+10% +$1,000K 4.88% 5
2021
Q3 		$10.5M Buy
49,418
+3,521
+8% +$810K 4.65% 6
2021
Q2 		$11.2M Buy
45,897
+2,417
+6% +$595K 4.84% 5
2021
Q1 		$10.8M Buy
43,480
+20,697
+91% +$4.94M 5.44% 4
2020
Q4 		$5.24M Buy
22,783
+2,869
+14% +$661K 2.95% 15
2020
Q3 		$5.06M Sell
19,914
-1,049
-5% -$260K 3.18% 16
2020
Q2 		$4.94M Sell
20,963
-460
-2% -$105K 3.12% 15
2020
Q1 		$4.34M Buy
21,423
+296
+1% +$64.7K 3.34% 15
2019
Q4 		$5.09M Sell
21,127
-729
-3% -$161K 3.06% 17
2019
Q3 		$4.23M Buy
21,856
+1,162
+6% +$223K 2.8% 20
2019
Q2 		$3.81M Buy
20,694
+2,224
+12% +$398K 2.52% 19
2019
Q1 		$3.51M Buy
18,470
+837
+5% +$160K 2.27% 21
2018
Q4 		$3.43M Sell
17,633
-295
-2% -$57.6K 2.47% 19
2018
Q3 		$3.72M Sell
17,928
-67
-0.4% -$13.2K 2.33% 20
2018
Q2 		$3.32M Buy
17,995
+2,921
+19% +$517K 2.23% 21
2018
Q1 		$2.57M Buy
15,074
+683
+5% +$125K 1.79% 25
2017
Q4 		$2.5M Buy
+14,391
New +$2.55M 1.7% 26

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Biechele Royce Advisors's AMGN Position: Q3 2024 in Review

Biechele Royce Advisors reduced its Amgen (AMGN) stake by 3.3% in Q3 2024, selling an estimated $727K and leaving 64,848 shares worth $20.9M. The position accounts for 6.89% of the portfolio, ranked #4.

Biechele Royce Advisors first reported a position in AMGN in Q4 2017 and has held it in 28 quarters since. The position peaked at $21M in Q2 2024. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Biechele Royce Advisors held 64,848 shares of Amgen worth $20.9M as of Q3 2024.
  • Biechele Royce Advisors sold 2,224 Amgen shares in Q3 2024, an estimated $727K.
  • Amgen made up 6.89% of Biechele Royce Advisors's portfolio in Q3 2024, its #4 holding.
  • Biechele Royce Advisors first reported a position in Amgen in Q4 2017 and has held it in 28 quarters since.
  • Biechele Royce Advisors's Amgen position peaked at $21M in Q2 2024.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Biechele Royce Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.